Please login to the form below

Not currently logged in
Email:
Password:

Prescient names vice president global head of advisory

Dr Debasish Talukdar joins the consultancy from Bain & Company

Debasish TalukdarPrescient Healthcare Group, a biopharmaceutical product strategy and decision support consultancy, has named Dr Debasish Talukdar as its new vice president, global head of advisory.

His new role will see him take responsibility for the future trajectory for the group’s advisory practice.

Talukdar said: “I’m very excited to have joined Prescient and see huge opportunity to grow VantageRX, our advisory services business.

“We have an incredible team that offers a differentiated level of service to our clients through in-depth technical, therapeutic and market expertise.”

He joins the group from Bain & Company, where he was a leader in the healthcare practice gaining expertise in advising biopharma clients on value creation through corporate, business unit, disease area and product-focused strategies.

Jamie Denison-Pender, chief executive officer of Prescient, said: “His [Talukdar] tier 1 consultancy experience coupled with his medical background makes him a fantastic fit for us.

“Debasish has a real passion for problem solving and is an expert at understanding the nuances associated with a client need and then framing an optimal solution.”

27th February 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics